BrightOwl Loader Loading


With almost 20 years experience in multinational and start-up organizations. Dynamic, entrepreneurial, innovative, sklled at managing both projects and people, able to motivate a team towards achievement of the objectives, excellent communication and negotiation skills. Excellent knowledgement of Clinical /non-interventional trials, registries management (from designing of protocol to study report) within EMEA and US area Involvement on non clinical and preclinical activities Involvement on the development of Post Approval studies, Real World Data to reach regulatory environment, marketing ..... target Good understanding of Health Economics and Market Access (negotiations, dealing with authorities, payors, stakeholders)


Current Experience

  • Clinical Expert Consultant
    Since May 2014

  • Independent Expert Evaluator
    Since January 2014
    Independent Expert for European Commission assists with research and innovation assignments including the evaluation of proposals, monitoring of projects, and evaluation of programmes, and design of policy. Assignments mainly concern research and innovation, falling within the Horizon 2020 programme designed to address the challenges Europe is facing through funding excellent science, technology and innovation.

  • Managing Director // Freelance Consultant and business owner
    Since July 2011
    Freelance Consultant and business owner Expert on Clinical developement and execution of programs ( Phase I to IV, Post-Approval Studies, Real World Data, Observational studies..........) Outcomes Research......................... Helping clients optimise the drug development pathways of their products through Europe Midle East Africa area Designing of programs/projects strategy from study feasibility to report or submission

Past Experience

  • Clinical Research Expert
    July 2011 --- March 2013
    Working for Uteron-Pharma as Clinical Research Director/Expert Uteron Pharma is a female healthcare company focussed on providing high value products relating to (i) Contraception and fertility (ii) Menopause and osteoporosis (iii) Utero-vaginal sphere and (iv) Female cancer Development of the non-clinical and clinical programs Executing company clinical/non-clinical strategy

  • Professeur - invité
    January 2006 --- January 2013

  • Professeur - invité
    January 2006 --- January 2013

  • Health Outcomes Research Manager
    September 2008 --- July 2011
    2 types of activities • Development of Registry programs and other non-interventional programs in Europe, Middle-East and Africa (planning, preparation, execution, coordination and management of the assigned programs) • Participate to the development and interpretation of health economic arguments in order to optimize market access • Mapping of local requirements for market entry from a reimbursement / hospital perspective • Strategic guidance in pricing and reimbursement • Local adaptation of health economic models for reimbursement or hospital access • Preparation of tender documents when required • Participate to the communication of value messages to key decision makers at different levels within the health care sector

  • Global PM / Head of Customer Services Late Phase
    January 2006 --- September 2008

  • Global PM
    January 2004 --- January 2006

  • Chef Projet
    January 2001 --- January 2004


BrightOwl Assessment :
ResiliencyPerspectiveDiligenceStrivingSociabilityCreative thinking


BrightOwl Assessment :
Good Clinical Practice (GCP)Good Clinical Practice (GCP)Emergency medicinePhases of clinical development (phase I to IV)Preclinical regulations and practicesClinical DevelopmentNegotiation
LinkedIn Assessment :
Clinical trialsClinical DevelopmentPharmaceutical IndustryCRORegulatory affairsGCPBiotechnologyClinical researchCTMSoncologyPharmacovigilanceLifesciencesCross-culturalCross Functional Team BuildingPartnership-buildingLeadershipRegulatory submissionsHealthcareOutcomes ResearchClinical monitoringICH-GCPHealth EconomicsMarket accessProtocolMedical affairsVaccinesImmunologyClinical Data Management (CDM)CancerDrug DevelopmentTherapeutic AreasMedical writingElectronic Data Capture (EDC) SOPHematologyCardiologyFDANeurologyPharmaceuticspharmacologyRegulatory RequirementsBiopharmaceuticalsDrug Discovery

Skills and Expertise

BrightOwl Assessment :
Develop ICH/GCP compliant processesPlan work to meet objectives and deadlinesEnsure good clinical practice (GCP)Supervise clinical monitorsCoach and provide guidance to clinical staff.Develop and maintain tracking systemsEthics committee submissions


  • MBA (Pharma mini Executive) in Pharmaceutical Sciences from London Business School in 2012
  • PhD in Boichemystry / Immunology from Université Pierre Marie Curie (VI) France in 1996
  • in from Université Pierre et Marie Curie (Paris VI) in 0

Area / Region



Driving License
  • Yes